Affiliation:
1. Medical Genetics, Medical University of Vienna, Vienna, Austria
Abstract
Summary
Because of recent advances, the array of human pluripotent stem cells now contains embryonic stem cells, derived from “surplus” in vitro fertilization embryos or from cloned embryos; induced pluripotent stem cells; and amniotic fluid stem cells. Here, we compare these stem cell types regarding ethical and legal concerns, cultivation conditions, genomic stability, tumor developing potentials, and applicability for disease modeling and human therapy. This overview highlights that in the future appropriate methodological management must include a decision on the “optimal” stem cell to use before the specific application
Publisher
Oxford University Press (OUP)
Subject
Cell Biology,Developmental Biology,General Medicine
Reference23 articles.
1. Investigating monogenic and complex diseases with pluripotent stem cells;Zhu;Nat Rev Genet,2011
2. Transfusions et greffes de moelle osseuse homologue chez des humains irradiés à haute dose accidentellement [in French];Mathe;Rev Fr Etud Clin Biol,1959
3. Stem cell based therapy—Where are we going?;Ilic;Lancet,2012
4. Amniotic fluid stem cells and fetal cell microchimerism;Rosner;Trends Mol Med,2013
5. Human embryonic stem cells derived by somatic cell nuclear transfer;Tachibana;Cell,2013
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献